Trials / Not Yet Recruiting
Not Yet RecruitingNCT06890533
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery
A Phase Ⅲ, Randomized, Double-Blind, Placebo- and Active-controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Abdominal Surgery
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 560 (estimated)
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Experimental: YZJ-4729 | Loading dose + demand dose |
| DRUG | Placebo Comparator: Saline | Loading dose + demand dose |
| DRUG | Active Comparator: Morphine | Loading dose + demand dose |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-06-01
- Completion
- 2026-09-01
- First posted
- 2025-03-24
- Last updated
- 2025-03-24
Locations
49 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06890533. Inclusion in this directory is not an endorsement.